Definition of the Sentinel Lymph Node and Basic Principles of Detection


Breast Cancer Sentinel Lymph Node Sentinel Node Biopsy Gamma Probe Sentinel Node Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Adler LP, Faulhaber PF, Schnur Kc, Al-Kasi NL, Shenk RR (1997) Axillary lymph node metastases: screening with (F-18)2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 203:323, 327PubMedGoogle Scholar
  2. Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdson H (1991) ErbB2 amplification in breast cancer with high rate of proliferation. Oncogene 6:137–143PubMedGoogle Scholar
  3. Borgstein PJ, Pijpers R, Comans EF, van-Diest PJ, Boom RP, Meijer S (1998) Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J AM Coll Surg 186:275–283CrossRefPubMedGoogle Scholar
  4. Dixon M (1998) Sentinel node biopsy in breast cancer. BMJ 317:295–296PubMedGoogle Scholar
  5. Marx D, Schauer A, Reiche C, May A, Ummenhofer L, Reles A, Rauschecker HF, Sauer R, Schumacher M (1990) cerbB2-expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 116:15–20PubMedGoogle Scholar
  6. Min CJ, Tafra L, Verbanac KM (1998) Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph-nodes. Cancer Res 15(58):4581–4584Google Scholar
  7. Rovere G della, Bird PA (1998) Sentinel lymph node in breast cancer. Lancet 352:421–422CrossRefPubMedGoogle Scholar
  8. Schauer A, Marx D, Ummenhofer L, Rauschecker H, Gatzemeier W, Sauer R, Schumacher M, Sauerbrei W (1990) Die Multicenter Studie „Kleines Mammacarcinom. Vorläufige Ergebnisse — Neue Aspekte“. Dtsch Ärzteblatt 87:3628–3638Google Scholar
  9. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida ST, Bodeni N, Costa A, Chicco C, Geraghty JG, Luine A, Sacchini V, Veronesi P (1997) Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864–1867CrossRefPubMedGoogle Scholar
  10. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L (1990 a) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175:489–493PubMedGoogle Scholar
  11. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ (1990 b) Ultrasmall superparamagnetic iron oxide: an i.v. contrast agent for assessing lymph-nodes with MR imaging. Radiology 175:494–498PubMedGoogle Scholar
  12. Weissleder R, Heautot JF, Schaffer BK, Nossiff N, Papisov M, Bogdanov AJ, Brady T (1994) MR lymphography study of a high efficiency lymphography agent. Radiology 191:225–230PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations